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ABSTRACT
83-year-old man was referred to a clinic due to exacerbation 
of chronic heart failure. CRT-D interrogation revealed lack of 
efficient left ventricular pacing. Patient was qualified to the left 
ventricular lead reposition. Due to anatomical conditions and 
technical limitations it was decided to stabilize the lead with 
the bioresorbable vascular scaffold.
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STRESZCZENIE
Mężczyzna, 83-letni, został skierowany do kliniki z powodu 
zaostrzenia przewlekłej niewydolności serca. Interrogacja CRT-D 
wykazała brak skutecznej stymulacji lewej komory, a pacjent 
został zakwalifikowany do repozycjonowania lewej elektrody. 
Ze względu na trudne warunki anatomiczne i techniczne ogra-
niczenia, podjęto decyzję o wykonaniu stabilizacji przy użyciu 
rusztowania bioresorbowalnego.
Słowa kluczowe: rusztowanie bioresorbowalne, terapia 
resynchronizująca, dyslokacja elektrody.
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Case report
A 83-year-old man was referred to a clinic due to 
exacerbation of chronic heart failure (CHF) to New 
York Heart Association (NYHA) class III. Six months 
prior to current admission he was implanted with 
cardiac resynchronization therapy with defibrillator 
(CRT-D) due to decreased left ventricular ejection 
fraction (LVEF = 26%), right bundle branch block and 
paroxysmal 2:1 atrio-ventricular block. His medical 
history was also positive for myocardial infarction, 
hypertension and type 2 diabetes mellitus.
CRT-D interrogation revealed lack of efficient left 
ventricular pacing and chest X-ray confirmed ma-
cro-dislocation of a left ventricular lead from po-
stero-lateral branch of coronary sinus. Patient was 
qualified to the left ventricular (LV) lead reposition. 
Due to anatomical conditions, phrenic nerve stimu-
lation in the second available lateral vein only the 
same posterolateral side branch was feasible for LV 
lead implantation. After introduction of the lead and 
confirmation of acceptable pacing parameters it was 
decided to stabilize the lead with the bioresorbable 
vascular scaffold (BVS). The 2.5 × 8 mm Absorb GT1 
(Abbott Vascular) was implanted at 16 atm (Fig. 1). 
Size of the BVS and its proper expansion were 
assessed in pre- and postprocedural intravascular 
ultrasound (IVUS) imaging (Fig. 2).
During 6-month follow-up the patient was found in 
good general condition with NYHA class II symptoms 
and stable electrical parameters of LV lead. 
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Discussion
Cardiac resynchronization therapy has been es-
tablished as an effective therapy for patients with 
symptomatic heart failure with reduced ejection 
fraction and wide QRS complex mainly with left 
bundle branch block morphology [1]. CRT should 
also be considered in patients with indications to 
antybradycardia pacing with reduced left ventri-
cular function to prevent HF exacerbations [1]. In 
our case reduced EF and wide QRS complex, al-
though of RBBB morphology, were accompanied 
by atrio-ventricular conduction disturbances and 
patient’s condition clearly worsened with loss of 
resynchronization. 
Dislodgement of the left ventricular lead occurs 
in up to 10% of cases and remain one of the main 
complications of CRT [2]. Active fixation LV leads 
like Attain Starfix OTW LV (Medtronic, USA) reduced 
the rate of dislodgements but are not widely used 
because of potential problems during transcutaneous 
lead extraction procedures [3]. 
Target zone for left ventricular pacing is located 
in basal and mid segments of lateral wall of left 
ventricle. This location along with passive fixation 
makes the displacement significantly more likely. 
However, there is no recognized proper method of 
stabilization. Well described, but not flawless method 
is stabilization with metal stent [4–6]. Long-term 
studies have shown that this technique is safe and 
only about 5% of patients with coronary sinus side 
branch stenting stabilization needed additional in-
tervention [7]. Nevertheless, potential complications 
due to stent implantation like lead damage, injury of 
the cardiac vein and limitations in lead extraction still 
remains. Some of these problems may be probably 
avoided by using the biodegradable scaffold instead 
of metal stents. This technique, recently described 
by Wipert et al., seems to have some advantages like 
thrombotic and fibrotic active fixation, lower risk of 
future lead damage and easier extractability because 
of nonpermanent trapping [8]. Proper implantation 
of vascular scaffold into cardiac vein may be chal-
lenging. In our case IVUS was used to confirm the 
proper size, location and expansion of the scaffold.
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Figure 1. Implantation of bioresorbable vascular scaffold to 
posterolateral branch of coronary sinus
Figure 2. The course of left ventricular lead and stabilization with bioresorbable vascular scaffold shown in IVUS imaging. A. Preprocedural 
imaging showing free-floating LV lead (white arrow); B. Image after BVS implantation showing LV lead (black arrow) that is pushed to the vessel 
wall
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